+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy



Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy



British Journal of Haematology 167(1): 133-136




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052469331

Download citation: RISBibTeXText

PMID: 24797533

DOI: 10.1111/bjh.12930


Related references

Follicular large cell lymphoma treated by intensive chemotherapy An analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large cell lymphoma. Blood 86(10 Suppl. 1): 440A, 1995

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Annals of Oncology 8(11): 1125-1132, 1997

Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology 15(4): 1654-1663, 1997

Diffuse large cell lymphoma and t(8;22) (q24;q11) in a patient with idiopathic CD4+ T-lymphopenia. Leukemia and Lymphoma 41(3-4): 421-423, 2001

Three cases of diffuse large B-cell lymphoma of the mandible treated with radiotherapy and chemotherapy. Radiation Medicine 23(4): 296-302, 2005

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma CISL. Journal of Hematology & Oncology 5(1), 2012

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). Journal of Hematology and Oncology 5: 49, 2012

CD3-positive diffuse large B-cell lymphoma relapses as CD3-negative large B-cell lymphoma: Loss of aberrant antigen expression in B-cell lymphoma after chemotherapy. Pathology Research and Practice 214(10): 1738-1744, 2018

Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy. International Journal of Clinical and Experimental Medicine 7(2): 456-460, 2014

Partial remission of a newly diagnosed diffuse large B-cell Non-Hodgkin's lymphoma in a hemodialysis patient after administration of immuno-chemotherapy with rituximab-CHOP. International Journal of Laboratory Hematology 29(6): 469-473, 2007

Factors predicting response and survival in diffuse large cell lymphoma treated with combination chemotherapy. Proceedings American Society of Clinical Oncology Annual Meeting 5: 197, 1986

Characteristics And Outcome Of Patients With Diffuse Large B Cell Lymphoma-Treated With Chemotherapy Or Chemo-Immunotherapy. Journal of Ayub Medical College Abbottabad 28(2): 254-258, 2017

Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapy. Acta Haematologica 120(3): 150-152, 2008

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Annals of Oncology 22(7): 1601-1607, 2011

Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy. ImmunoTherapy 11(4): 265-272, 2019